Back to results
US 2012/0237487 A1Published application
Mesenchymal stem cell and the method of use thereof
AssigneeNc Medical Research Inc.
InventorsOsamu Honmou, Kazuo Hashi, Teiji Uede
Life of this patent
Estimating the term…
Abstract
Demyelinated axons were remyelinated in the demyelinated rat model by collecting bone marrow cells from mouse bone marrow and transplanting the mononuclear cell fraction separated from these bone marrow cells.
Claims1
A method for treating neurodegenerative diseases, comprising:
- injecting an effective amount of cells capable of differentiating into neural cells or glia cells into a patient afflicted with a neurodegenerative disease,
- wherein the cells are prepared by a method comprising:
- diluting marrow cells or cord blood cells;
- isolating a mononuclear cell fraction;
- and
- selecting cells having surface markers SH2(+), SH3(+), SH4(+), CD29(+), CD44(+), CD14(−), CD34(−), and CD45(−) from the mononuclear cell fraction, and
- wherein the injected cells treat said patient's neurodegenerative disease.
4 more elements
Dependencies are inferred from the claim text.